Drug Database
Back to search

United States· US:68118-500_5c2bec09-4b38-0d96-e063-6394a90aeb0e

Zanosar

A streptozocin product containing streptozocin, registered in United States by ESTEVE PHARMACEUTICALS, S.A.. The same ATC class is registered in 9 of our 19 countries.

ATC L01AD04

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedZanosarATCL01AD04REGISTER NO.US:68118-500_5c2bec09…PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about streptozocinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Streptozocin is registered in 9 of 19 countries.

Countries holding a registration under ATC L01AD04 (streptozocin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 5 of them publish a price we can compare per daily dose
Search streptozocin products by name

Streptozocin · ATC L01AD04

9 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
STREPTOZOCIN
Manufacturer
ESTEVE PHARMACEUTICALS, S.A.
Country
United States (US)
ATC code
L01AD04
ATC class
Streptozocin
Defined daily dose
96 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    68118-500-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

151 interactions on record for streptozocin.

Graded by severity as the source publishes them — 40 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check streptozocin against other medicinesHow interaction checks work

Streptozocin · interactions on record

151 records

  • 40 severe
  • 97 moderate
  • 14 minor

Most severe, free to view

  • Nalidixic acidJ01MB02severe
  • CidofovirJ05AB12severe
  • ThiotepaL01AC01severe
  • CladribineL01BB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Streptozocin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All streptozocin products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Belgium · Streptozocine Esteve
  • Germany · Zanosar
  • Denmark · Zanosar
  • Spain · Zanosar
  • Finland · Zanosar
  • France · Zanosar
  • United Kingdom (Northern Ireland) · Zanosar
  • Italy · Streptozocina Keocyt
  • Netherlands · Zanosar
  • Norway · Zanosar
  • Sweden · Zanosar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7252c1bb-a5b0-4ebe-802f-9a60fbebb64f
GET /v1/drugs/7252c1bb-a5b0-4ebe-802f-9a60fbebb64f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "1",
  "substance": "STREPTOZOCIN",
  "productndc": "68118-500",
  "dosage_form": "POWDER, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "g/10mL",
  "application_number": null,
  "marketing_category": "UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE"
}
API referenceMCP serverPlans

See everything about streptozocin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console